European healthcare investor GHO Capital has acquired a majority stake in active pharmaceutical ingredient (API) manufacturer, Sterling Pharma Solutions.
M&As
The Newcastle-based company delivers a full-service offering of API development and GMP manufacturing.
GHO Capital is expected to bring its extensive sectoral expertise and networks in the global pharmaceutical industry to help accelerate Sterling's international growth.
Kevin Cook, CEO of Sterling Pharma Solutions, commented: “We are delighted to partner with GHO Capital, whose expertise in the pharmaceuticals space and track record of supporting companies expand internationally will be invaluable in facilitating the next stage of our growth in Europe and in the US.”
Alan MacKay, Partner at GHO Capital, said: “Sterling provides a compelling opportunity to partner with a best in class Management team to support the global demand for complex chemistry in pharmaceuticals.”
“Sterling is today a leader in Europe from its UK operations and the plan is to extend Sterling’s international presence to meet increasing demand from customers worldwide.”